Chapter 9 Changes in Neurotransmitter Signal Transduction Pathways in the Aging Brain

Advances in Cell Aging and Gerontology

Volumn 2, Issue C, 1997, Pages 243-278

  Kelly, Jeremiah F ^a   Roth, George S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345590985     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(08)60059-0     Document Type: Article

References (145)

1. Altavista M.C., Bentivoglio A.K., Crociani P., Rossi P., and Albanese A. Aging and brain cholinergic receptors: an autoradiographic study in rat. Brain Res. 455 (1988) 177-181
2. Amenta F., Franch F., Ricci A., and Vega J.A. Cholinergic neurotransmission in the hippocampus of aged rats: influence of L-alpha-glycerylphophorylcholine treatment. Ann. N. Y. Acad. Sci. 695 (1993) 311-313
3. Amenta F., Zaccheo D., and Collier W.L. Neurotransmitters, neuroreceptors and aging. Mech. Aging Dev. 61 (1991) 249-273
4. Andriamampandy C., Kanfer J.N., Freysz L., Dreyfus H., and Massarelli R. In vitro and in vivo ethanolamine metabolism in rat brain: effect of time and aging. Neurobiol. Aging 13 (1992) 435-440
5. Anson R.M., Cutler R., Joseph J.A., Yamagami K., and Roth G.S. The effect of aging on muscarinic receptor/G-protein coupling in the rat hippocampus and striatum. Brain Res. 598 (1992) 302-306
6. 11C-raclopride. Arch. Neurol. 50 (1993) 474-480
7. Arnsten A.F.T., Cai J.X., Murphy B.L., and Goldman-Rakic P.S. Dopamine Dl receptor mechanisms in the cognitive performance of young and aged monkeys. Psychopharmacol. 116 (1994) 143-151
8. Arnsten A.F.T., Cai J.X., Steere J.C., and Goldman-Rakic P.S. Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: The effects of quinpirole on memory and motor performance in monkeys. J. Neurosci. 15 (1995) 3429-3439
9. Arranz B., Eriksson A., Mellerup E., Plenge P., and Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res. 620 (1993) 163-166
10. Bahr B.A., Godshall A.C., Hall R.A., and Lynch G. Mouse telencephalon exhibits an age-related decrease in glutamate (AMPA) receptors but no change in nerve terminal markers. Brain Res. 589 (1992) 320-326
11. Bannon M.J., Poosch M.S., Xia Y., Goebel D., Cassin B., and Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Nat. Acad. Sci. USA 89 (1992) 7095-7099
12. Barnhill J.G., Greenblatt D.J., Miller L.G., Gaver A., Harmatz J.S., and Shader R.I. Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals. J. Pharmacol. Exp. Ther. 253 (1990) 1153-1161
13. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 214 (1982) 408-417
14. Biegon A., Duvdevani R., Greenberger V., and Segal M. Aging and brain choliergic muscarinic receptors: an autoradiographic study in the rat. J. Neurochem. 51 (1988) 1381-1385
15. Blake M.J., Appel N.M., Joseph J.A., Stagg C.A., Anson M., De Souza E.B., and Roth G.S. Muscarinic acetylcholine receptor subtype mRNA expression ligand binding inn the aged rat forebrain., Neurobiol. Aging 12 (1991) 193-199
16. Bourre J.M., and Piciotti M. Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci. Lett. 141 (1995) 65-68
17. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., and Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer p/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89 (1992) 10075-10078
18. Calne D.B., and Peppard R.F. Aging of the nigrostriatal pathway in humans. Can. J. Neurol. Sci. 14 (1987) 424-427
19. Choe M., Jackson C., and Yu B.P. Lipid peroxidation contributes to age-related membrane rigidity. Free Rad. Biol. Med. 18 (1995) 977-984
20. Choi J.H., and Yu B.P. Brain synaptosomal aging: free radicals and membrane fluidity. Free Rad. Biol. Med. 18 (1995) 133-139
21. Cordes M., Snow B.J., Cooper S., Schulzer M., Pate B.D., Ruth T.J., and Calne D.B. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Arch. Neurol. 36 (1994) 667-670
22. Crawford C.A., and Levine M.S. Dopaminergic function in the neostriatum and nucleus accumbens of young and aged Fischer 344 rats. Neurobiol. Aging 18 (1997) 57-66
23. Crews F.T., Kurian P., and Freund G. Cholinergic and serotonergic stimulation of phosphoinositide hydroysis is decreased in Alzheimer's disease. Life Sci. 55 (1994) 1993-2002
24. Cutler R., Joseph J.A., Yamagami K., Villalobos-Molina R., and Roth G.S. Area specific alterations in muscarinic stimulated low Km GTPase activity in aging and Alzheimer's disease: implications for altered signal transduction. Brain Res. 664 (1994) 54-56
25. Dax E.M. Age-related changes in membrane-receptor interactions. Endocrinology and Aging. Endocrinology and Metabolism Clinics (1987), W.B. Saunders, Philadelphia 947-960
26. De Keyser J., De Backer J., Vauquelin G., and Ebinger G. Dl and D2 dopamine receptors in human substantia nigra: localization and the effect of aging. J. Neurochem. 56 (1991) 1130-1133
27. Delion S., Chalon S., Guilloteau D., Besnard J.C., and Durand G. Alpha-linolenic acid dietary deficiency alters age-related changes in dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 66 (1996) 1582-1591
28. Della Vedova F., Fumagalli F., Sacchetti G., Racagni G., and Brunello N. Age-related variations in relative abundance fo alternative spliced D2 receptor mRNAs in brain areas of two rat strains. Mol. Brain Res. 12 (1992) 357-359
29. Dewey S.L., Vilkow N.D., Logan J., McGregor R.R., Fowler J.S., Schyler D.J., and Bendriem B. Age-related decrease in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J. Neurosci. Res. 27 (1990) 569-575
30. Dluzen D.E. Age-related changes in monoamines within the olfactory bulbs of the Fischer 344 male rat. Mech. Aging Dev. 91 (1996) 37-45
31. Dugar A., and Lakoski J.M. Serotonergic function of aging hippocampal CA3 phyramidal neurons: Electrophysiological assessment following adminsitration of 5,7-dihydroxytryptamine in the fimbria-fornix and cingulum bundle. J. Neurosci. Res. 47 (1997) 58-67
32. Enna S.J., Samirajki T., and Beer B. Brain neurotransmitters and receptors in aging and age-related disorders (1987), Raven Press, New York
33. Farde L. The advantage of using positron emission tomography in drug research. TINS 19 (1996) 211-214
34. Ferrari -DeLeo G., Mash DC., and Flynn D.D. Attenuation of muscarinic receptor-G protein interaction in Alzheimer disease. Molecular and Chemical Neuropathology 24 (1995) 69-91
35. Flicker C., Ferris S.H., and Serby M. Hypersensitivity to scopalamine in the elderly. Psychopharmacol. 107 (1992) 437-441
36. Flynn D.D., Weinstein D.A., and Mash D.C. Loss of high-affinity agonist binding to ml muscarinic receptor in Alzheimer's disease. Implications for failure of cholinergic replacement therapies. Ann. Neurol. 29 (1991) 256-262
37. Forster M.J., Dubey A., Dawson K., Stutts W.A., Lai H., and Sohal R.S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in brain. Proc. Natl. Acad. Sci. USA 93 (1996) 4765-4769
38. Fowler C.J., Garlind A., O'Neil C., and Cowburn R.F. Receptor-effector coupling dysfunctions in Alzheimer's Disease. Ann. N. Y. Acad. Sci. 786 (1996) 294-304
39. Friedman E., and Wang H. Effect of age on brain cortical protein kinase C and its mediation of 5-hydroxytryptamine release. J. Neurochem. 52 (1989) 187-192
40. Furukawa K., Barger S.W., Blalock E.M., and Mattson M.P. Activation of K+ channels and suppresison of neuronal activity by secreted β-amyloid precursor protein. Nature 379 (1996) 74-78
41. Gagne J., Giguere C., Tocco G., Ohayon M., Thompson R.F., Baudry M., and Massicotte G. Effect of phosphatidylserine on the binding properties of glutamate receptors in brain sections from adult and neonatal rats. Brain Res. 740 (1996) 337-345
42. Gazzaley A.H., Siegel S.J., Kordower J.H., Mufson E.J., and Morrison J.H. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc. Natl. Acad. Sci. USA 93 (1996) 3121-3125
43. Gelbmann CM., and Muller W.E. Chronic treatment with phosphotidylserine restores muscarinic cholinergic receptor deficits in the aged mouse brain. Neurobiol. Aging 13 (1991) 45-50
44. Gelbmann CM., and Muller W.E. Specific decrease of high-affinity agonist states of alphaj-adrenoreceptors in the aging mouse brain. J. Neural Transm. 79 (1990) 131-136
45. Ghosh C., Dick M.R., and Ali S.F. Iron/ascorbate-inducedlipidperoxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex. Neurochem. Int. 23 (1993) 479-484
46. Gilad G.M., Gilad V.H., and Tizabi Y. Aging and stress-induced changes in choline and glutamte uptake in hippocampus and septum of two rat strains differing in longevity and reactivity to stressors. Int. J. Dev. Neurosci. 8 (1990) 709-713
47. Giorgi O., Pibiri M.G., Dal Toso R., and Ragatzu G. Age-related changes in the turnover rates of Dl-dopamine receptors in the retina and in distinct areas of the rat brain. Brain Res. 569 (1992) 323-329
48. Goldman J.E., Calingasan N.Y., and Gibson G.E. Aging and the brain. Curr. Opinions Neurol. 7 4 (1994) 287-293
49. Gould T.J., Stromberg I., and Bickford P.C. Decline in striatal dopamine Dl and D2 receptor activation in aged F344 rats. Neurobiol. Aging 17 (1996) 877-883
50. Gozlon H., Daval G., Verge D., Spampinato U., Fattaccini CM., Gallissot M.C., El Mestikawy S., and Hamon M. Aging associated changes in serotonergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol. Aging 11 (1990) 437-449
51. Greenblatt D.J., Shader R.I., and Harmatz J.S. Implications of altered drug disposition in the elderly: studies of benzodiazepines. J. Clin. Pharmacol. 29 (1989) 866-872
52. Greenwood A.F., Powers RE., and Jope R.S. Phosphoinositidehydrolysis,G_q,phospholipase C., and protein kinase C in postmortem human brain: Effects of postmortem interval, subject age, and Alzheimer's disease. Neuroscience. 69 (1995) 125-138
53. Gutierrez A., Khan Z.U., Morris S.J., and De Bias A.L. Age-related decrease in GABAA receptor subunits and glutamic acid decarboxylase in the rat inferior colliculus. J. Neurosci. 14 (1994) 7469-7477
54. Han Z., Kuyatt B.L., Kochman K.A., DeSouza E.B., and Roth G.S. Effect of Aging on concentrations of D2 -receptor-containing neurons in rat striatum. Brain Res. 498 (1989) 299-307
55. Hartmann H., and Muller W.E. Age-related changes in receptor-mediated and depolarization-induced phosphatidylinositol turnover in mouse brain. Brain Res. 622 (1993) 86-92
56. Hatta S., Ozawa H., Saito T., and Ohshika H. Alteration of tubulin-G protein interaction in rat cerebral cortex with aging. J. Neurochem. 63 (1994) 1104-1110
57. Igbavboa U., Avdulov N.A., Schroeder F., and Wood W.G. Increasing age alters transbilayer fluidity and cholesterol asymetry in synaptic plasma membranes of mice. J. Neurochem. 66 (1996) 1717-1725
58. Ingram D.K., Garofalo P., Spangler E.L., Mantione C.R., Odano I., and London ED. Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res. 580 (1992) 273-280
59. Ingram D.K., Shimada A., Mukhin A., and London E.D. Evaluating the glutamate hypothesis of geriatric memory impairment: focus on hippocampal NMDA receptors. Perspectives in Brain Aging 1 (1996) 30-35
60. Iyo M., and Yamasaki T. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog, Neuropsychopharmacol. Biol. Psychiatr. 17 (1993) 415-421
61. Johnson M., Perry R.H., Piggott M.A., Court J.A., Spurden D., Lloyd S., Ince P.G., and Perry E.K. Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging. Neurobiol. Aging 17 (1996) 639-651
62. Jope R.S., Song L., and Powers R.E. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging 18 (1997) 111-120
63. Joseph J.A., Dalton T.K., and Hunt W.A. Age-related decrements in the muscarinic enhancement of K+ - evoked release of endogenous striatal dopamine: an indication of altered cholinergic-dopaminergic reciporcal inhibitory control in senescence. Brain Res. 454 (1988) 140-148
64. Joseph J.A., Dalton T.K., Roth G.S., and Hunt W.A. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand -muscarinic receptor interface. Brain Res. 454 (1988) 149-155
65. Joseph J.A., Roth G.S., and Strong R. The striatum, a microcosm for the examination of age-related alterations in the CNS: a selected review. Rev. Biol. Res. Aging 4 (1990) 181-199
66. Joseph J.A., Villalobos-Molina R., Denisova N., Erat S., Jimenez N., and Strain J. Increased sensitivity to oxidative stress and the loss of muscarinic receptor responsiveness in senescence. Ann. N. Y. Acad. Sci. 786 (1996) 112-119
67. Kametani H., Iijima S., Spangler E.L., Ingram D.K., and Joseph J.A. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol. Aging 16 (1995) 639-646
68. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., and Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Nat. Acad. Sci. USA 93 (1996) 6753-6758
69. Kelly J.F., Joseph J.A., Denisova N.A., Erat S., Mason R.P., and Roth G.S. Dissociation of striatal GTPase and dopamine release responses to muscarinic cholinergic agonists in F344 rats: influence of age and dietary manipulation. J. Neurochem. 64 (1995) 2755-2764
70. Kelly J.F., Mason R.P., Denisova N.A., Joseph J.A., Erat S., and Roth G.S. Age-related impairment in striatal membrane muscarinic cholinergic signal transduction is associated with reduced membrane bilayer width measured by small angle X-ray diffraction. BBRC. 213 (1995) 869-874
71. Kish S.J., Shannak K., Rajput A., Deck J.H.N., and Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58 (1992) 642-648
72. Kurian P., Narang N., and Crews F.T. Decreased carbachol-stimulated inositol 1,3,4,5-tetrakisphosphate formation in senescent rat cerebral cortical slices. Neurobiol. Aging 13 (1992) 521-525
73. 3H] CGS 19755. Neurobiol. Aging 17 (1996) 453-457
74. Ladner C.J., Celesia G.G., Magnuson D.J., and Lee J.M. Regional alterations in ml muscarinic receptor-G protein coupling in Alzheimer's disease. J. Neuropat. Exp. Neurol. 54 (1995) 783-789
75. Le Jeune H., Cecyre D., Rowe W., Meaney M.J., and Quirion R. Lonotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neurosci 74 (1996) 349-363
76. Lee H., Cozzi N.V., and Weiler M.H. Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices. J. Pharmacol. Exp. Ther. 258 (1991) 496-501
77. Li X., Greenwood A.F., Powers R., and Jope R.S. Effects of Postmortem interval, age, and Alzheimer's Disease on G proteins in human brain. Neurobiol. Aging 17 (1996) 115-122
78. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Liebergurg I., and Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the (3-amyloid precursor protein. Neuron 10 (1993) 243-254
79. 2 receptors during aging is partially due to decreased levels of mRNA. Brain Res. 545 (1991) 355-357
80. 3H] acetylcholine release. Mech. Aging Dev. 72 (1993) 119-128
81. Meyer E.M., Judkins J.H., Momol A.E., and Hardwick E.O. Effects of peroxidation and aging on rat neocortical ACh-release and protein kinase C. Neurobiol. Aging 15 (1994) 63-67
82. Michalek H., Fortuna S., and Pinter A. Age-related differences in brain choline acetyltransferase, chlinesterases and muscarinic receptor sties in two strains of rats. Neurobiol. Aging 10 (1989) 143-148
83. Miyamoto A., Aaraiso T., Koyama T., and Ohshika H. Membrane viscosity correlates with α-adrenergic signal transduction of the aged rat cerebral cortex. J. Neurochem. 55 (1990) 70-75
84. Miyazawa T., Suzuki T., and Fujimoto K. Age-dependent accumulation of phosphatidylcholine hydroperoxide in the brain and liver of the rat. Lipids 28 (1993) 789-793
85. Molchan S.E., Martinez R.A., Hill J.L., Weingartner H.J., Thompson K., Vitiello B., and Sunderland T. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res. Rev. 17 (1992) 215-226
86. Moore H., Stuckman S., Sarter M., and Bruno J.P. Potassium, but not atropine-stimulated cortical acetylcholine efflux, is reduced in aged rats. Neurobiol. Aging 17 (1996) 565-571
87. Morgan D.G., and May P.C. Age-related changes in synaptic neurochemistry. In: Schneider E.L., and Rowe J.W. (Eds). Handbook of the Biology of Aging (1990), Academic Press, Philadelphia 219-254
88. Muller W.E., Scheuer K., and Stoll S. Glutamatergic treatment strategies for age-related memory disorders. Life Sci. 55 (1994) 2147
89. Nabeshima T., Yamada K., Hayashi T., Hasegawa T., Ishihara S., Kameyama T., Morimasa T., Kaneyuki T., and Shohmori T. Changes in muscarinic cholinergic, PCP, GABAa, Dl and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats. Life Sci. 55 (1994) 1585-1593
90. Najlerahim A., Francis P.T., and Bowen D.M. Age-related alteration in excitatory amino acid neurotransmission in rat brain. Neurobiol. Aging 11 (1990) 155-158
91. Narang N. In situ determination of m1 and m2 muscarinic receptor binding sites and mRNA's in young and old rat brains. Mech. Aging Dev. 78 (1995) 221-239
92. Neer E.J. Heterotrimeric G proteins, organizers of transmembrane signals. Cell 80 (1995) 249-257
93. Neubig R. Membrane organization in G protein mechanisms. FASEB J. 8 (1994) 939-946
94. Nilsson O.G., and Gage F.H. Anticholinergic sensitivity in the aging rat septohippocampal system as assessed in a spacial memory task. Neurobiol. Aging 14 (1993) 487-497
95. Nitsch R.M., Slack B.E., Wurtman R.J., and Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258 (1992) 304-310
96. Nordberg A., Alafuzoff I., and Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31 (1992) 103-111
97. Ossowska K. Disturbances in neurotransmission processes in aging and age-related diseases. Polish J. Pharmacol. 45 (1993) 109-131
98. Pagliusi S.R., Gerrard P., Abdallah M., Talabot D., and Catsicas S. Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium permeability altered in hippocampal neurons. Neuroscience 61 (1994) 429-433
99. Palmer A.M., Robichaud P.J., and Reiter C.T. The release and uptake of excitatory amino acids in rat brain: Effect of aging and oxidative stress. Neurobiol. Aging 15 (1994) 103-111
100. Parent A., Rowe W., Meany M.J., and Quiron R. Increased production of inositol phosphates and diacylgylcerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. J. Pharmacol. Exp. Ther. 272 (1995) 1110-1116
101. Pascale A., Fortino I., Govoni S., Trabucchi M., Wetsel W.C., and Battaini F. Functional Impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J. Neurochem. 67 (1996) 2471-2477
102. Pearce B.D., and Potter L.T. Coupling of ml muscarinic receptors to G protein in Alzheimer's Disease. Alzh. Dis. Assoc. Disord. 5 (1991) 163-172
103. Rogers J. Efficient experimental design in aging studies. Neurobiol. Aging 12 (1991) 695-697
104. Rogers J., and Bloom F.E. Neurotransmitter metabolism and function in the aging central nervous system. In: Finch C.E., and Schneider E.L. (Eds). Handbook of the Biology of Aging (1985), Van Nostrand Reinhold, New York 645-691
105. Roth G.S. Changes in tissue responsiveness to hormones and neurotransmitters during aging. Exp. Gerontol. 30 (1995) 361-368
106. Roth G.S., Joseph J.A., and Mason R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. TINS 18 (1995) 203-206
107. Ruano D., Araujo F., Bentareha R., and Vitorica J. Age-related modifications on the GABAA receptor binding properties from Wistar rat prefrontal cortex. Brain Res. 738 (1996) 103-108
108. Ruano D., Benavides J., Machado A., and Vitorica J. Aging associated changes in the pharmacological properties of the benzodiazepine (w) receptor isotypes in the rat hippocampus. J. Neurochem. 64 (1995) 867-873
109. 2 with monoamine oxidase-B sites. J. Neurochem. 61 (1993) 881-889
110. Sastre M., and Garcia-Sevilla J.A. Density of alpha-2A adrenoreceptors and Gi proteins in the human brain: Ratio of high-affinity agonist sites to antagonist sites and effect of age. J. Pharmacol. Exp. Ther. 269 (1994) 1062-1072
111. Sawada M., Sester U., and Carlson J.C. Superoxide radical formation and associated biochemical alterations in the plasma membrane of brain, heart, and liver during the lifetime of the rat. J. Cellular Biochem. 48 (1992) 296-304
112. Sawle G.V., Colebatch J.G., Shah A., Brooks D.J., Marsden CD., and Franckowiak M.D. Striatal function in normal aging: implications for Parkinson's Disease. Ann. Neurol. 28 (1990) 799-804
113. Scarpace P.J., and Abrass I.B. Alpha- and beta-adrenergic receptor in the brain during senescence. Neurobiol. Aging 9 (1988) 53-58
114. Schroeder F., Gorka C., and Wood W.G. Neuronal membrane asymetry and aging. In: Strong R. (Ed). Central nervous system disorders of aging: clinical intervention and research (1988), Raven Press, New York 211-222
115. Sherman K.A., and Friedman E. Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: new findings and an interpretative review. Int. J. Devel. Neurosci. 8 (1990) 689-708
116. 3H] dopamine uptake in rat striatum during aging. J. Neurochem. 56 (1991) 575-579
117. Shinitzky M. Patterns of lipid changes in membranes of the aged brain. Gerontology 33 (1987) 149-154
118. Simpkins J.W., and Millard W.J. Influence of age on neurotransmitter functions. Endocr. Metab. Clin. 16 (1987) 893-917
119. Smith C.J., Perry E.K., Perry R.H., Fairburn A.F., and Birdsall N.J.M. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem brain-a preliminary study in Alzheimer's Disease. Neurosci. Lett. 82 (1987) 227-232
120. Spangler E.L., Waggie K., Rea W., Roberts D., Hengemihle J., Danon D., and Ingram D.K. Relationship of hematological variables to learning performance in aged Fischer-344 rats. Neurobiol. Aging 16 (1995) 85-89
121. Strosznajder J., Samochocki M., and Duran M. Aging diminishes serotonin-stimulated arachadonic acid uptake and cholinergic receptor-activated arachadonic acid release in rat brain cortex membrane. J. Neurochem. 62 (1994) 1048-1054
122. Suhara T., Fukuda H., Inoue O., Itoh T., Suzuki K., Yamasaki T., and Tateno Y. Age-related changes in human Dl dopamine receptors measured by positron emission tomography. Psychopharmacology 103 (1991) 41-45
123. Tanaka Y., Hasagawa A., and Ando S. Impaired synaptic function with aging as characterized by decreased calcium influx and acetylcholine release. J. Neurosci. Res. 43 (1996) 63-70
124. Tanila H., Taira T., Pieponen T.P., and Honkanen A. Effect of sex and age on brain monoamines and spatial learning in rats. Neurobiol. Aging 15 (1994) 733-741
125. Tariot P.N., Patel S.V., Cox C., and Henderson R.E. Age-related decline in central cholinergic function demonstrated with scopolamine. Psychopharmacology 125 (1996) 50-56
126. Tien J.Z., Huerta P.T., and Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87 (1996) 1327-1338
127. Turgeon S.M., and Albin R.L. GAB AB binding sites in early adult and aging rat brain. Neurobiol. Aging 15 (1994) 705-711
128. Undie A.S., and Freidman E. Aging-induced decrease in dopaminergic-stimulated phosphoinositide metabolism in rat brain., Neurobiol. Aging 13 (1992) 505-511
129. Undie A.S., Wang H., and Friedman E. Decreased phospholipase C-β immunoreactivity, phosphoinositide metabolism, and protein kinase C activation in senescent F-344 rat brain. Neurobiol. Aging 16 (1996) 19-28
130. Valerio A., Belloni M., Gorno M.L., Tinti C., Memo M., and Spano P. Dopamine D2, D3 and D4 receptor mRNA levels in rat brain and pituitary during aging. Neurobiol. Aging 15 (1994) 713-719
131. Vannucchi M.G., and Goldman-Rakic P.S. Age-dependent decrease in the affinity of muscarinic Ml receptors in neocortex of rhesus monkeys. Proc. Nat. Acad. Sci. USA 88 (1991) 11475-11479
132. Villalobos-Molina R., Joseph J.A., and Roth G.S. OC-Adrenergic stimulation of low Km GTPase in rat striata is diminished with age. Brain Res. 590 (1992) 303-304
133. Wang G., Volkow N.D., Logan J., Fowler J.S., Schlyer D., MacGregor R.R., Hitzemann R.J., Gur R.C., and Wolf A.P. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sci. 56 (1995) 249-253
134. Wang H.Y., and Friedman E. Receptor mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. Neurosci. Lett. 173 (1994) 37-39
135. 1-like dopamine sites in rat striatum: Possible role in dopamine-mediated inositol phosphate formation. J. Pharmacol. Exp. Ther. 48 (1995) 988-994
136. Warpman U., Alafuzoff I., and Nordberg A. Coupling of muscarinic receptors to GTP proteins in postmortem human brain-alterations in Alzheimer's disease. Neurosci. Lett. 150 (1993) 39-43
137. Wenk G.L., Walker L.C., Price D.L., and Cork L.C. Loss of NMDA, but not GABAA, binding in the brains of aged rats and monkeys. Neurobiol. Aging 12 (1991) 93-98
138. West M.J., Coleman P.D., Flood D.G., and Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344 (1994) 769-772
139. Wolf B.A., Wertkin A.M., Jolly Y.C., Yasuda R.P., Wolfe B.B., Konrad R.J., Manning D., Ravi S., Williamson J.R., and Lee M. Muscarinic regulation of Alzheimer's Disease amyloid precrusor protein secretion and amyloid β-protein production in human NT2N cells. J. Biol. Chem. 270 (1995) 4916-4922
140. Yamagami K., Joseph J.A., and Roth G.S. Muscarinic receptor concentrations and dopamine release in aged rat striatum. Neurobiol. Aging 13 (1991) 51-56
141. Yamagami K., Joseph J.A., and Roth G.S. Decrement of muscarinic receptor-stimulated low Km GTPase in striatum and hippocampus from aged rat. Brain Res. 576 (1992) 327-331
142. Yeung J.M., and Freidman E. Effect of aging and diet restriction on monoamines and amino acids in cerebral cortex of Fischer-344 rats. Growth, Devel. Aging 55 (1991) 275-283
143. Young L.T., Warsh J.J., Li P.P., Siu K.P., Becker L., Gilbert J., Hornykiewicz O., and Kish S.J. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Devel. Brain Res. 61 (1991) 243-248
144. Yu B.P., Chen J.J., Kang CM., Choe M., Maeng Y.S., and Kristal B.S. Mitochondrial aging and lipoperoxidative products. Ann. N. Y. Acad. Sci. 786 (1996) 44-56
145. Zhang X., Wahlstrom G., and Nordberg A. Influence of development and aging on nicotinic receptor subtypes in rodent brain. Int. J. Devi. Neurosci. 8 (1990) 715-721